Neoantigen DNA vaccines are safe, feasible, and capable of inducing neoantigen-specific immune responses in patients with triple negative breast cancer
Xiuli Zhang, S. Peter Goedegebuure, Nancy B. Myers, Tammi Vickery, Michael D. McLellan, Feng Gao, Mark A. Sturmoski, Michael Y. Chen, Samuel W. Kim, Ina Chen, Jesse T Davidson 4th, Narendra V. Sankpal, Jasreet Hundal, Lijin Li, Stephanie Myles, Rama Suresh, Cynthia X. Ma, Ademuyiwa Foluso, Andrea Wang-Gillam, Sherri Davies, Ian Hagemann, Elaine R. Mardis, Malachi Griffith, Christopher A. Miller, Ted H. Hansen, Timothy P. Fleming, Robert D. Schreiber, William E. Gillanders
doi: https://doi.org/10.1101/2021.11.19.21266466
Xiuli Zhang
1Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA
S. Peter Goedegebuure
1Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA
6The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Saint Louis, MO, USA
Nancy B. Myers
1Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA
Tammi Vickery
3Bursky Center for Human Immunology & Immunotherapy Programs, Washington University School of Medicine, Saint Louis, MO, USA
5Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, USA
Michael D. McLellan
4McDonnell Genome Institute, Washington University School of Medicine, Saint Louis, MO, USA
Feng Gao
1Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA
Mark A. Sturmoski
1Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA
Michael Y. Chen
1Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA
Samuel W. Kim
1Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA
Ina Chen
1Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA
Jesse T Davidson 4th
1Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA
Narendra V. Sankpal
1Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA
Jasreet Hundal
4McDonnell Genome Institute, Washington University School of Medicine, Saint Louis, MO, USA
Lijin Li
1Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA
Stephanie Myles
6The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Saint Louis, MO, USA
Rama Suresh
2Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA
6The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Saint Louis, MO, USA
Cynthia X. Ma
2Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA
6The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Saint Louis, MO, USA
Ademuyiwa Foluso
2Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA
6The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Saint Louis, MO, USA
Andrea Wang-Gillam
2Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA
6The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Saint Louis, MO, USA
Sherri Davies
Ian Hagemann
5Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, USA
Elaine R. Mardis
4McDonnell Genome Institute, Washington University School of Medicine, Saint Louis, MO, USA
6The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Saint Louis, MO, USA
7Nationwide Children’s Hospital and The Ohio State University College of Medicine, Department of Pediatrics, Columbus, OH, USA
Malachi Griffith
4McDonnell Genome Institute, Washington University School of Medicine, Saint Louis, MO, USA
Christopher A. Miller
4McDonnell Genome Institute, Washington University School of Medicine, Saint Louis, MO, USA
Ted H. Hansen
5Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, USA
Timothy P. Fleming
1Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA
6The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Saint Louis, MO, USA
Robert D. Schreiber
3Bursky Center for Human Immunology & Immunotherapy Programs, Washington University School of Medicine, Saint Louis, MO, USA
5Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, USA
6The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Saint Louis, MO, USA
William E. Gillanders
1Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA
6The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Saint Louis, MO, USA
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted November 21, 2021.
Neoantigen DNA vaccines are safe, feasible, and capable of inducing neoantigen-specific immune responses in patients with triple negative breast cancer
Xiuli Zhang, S. Peter Goedegebuure, Nancy B. Myers, Tammi Vickery, Michael D. McLellan, Feng Gao, Mark A. Sturmoski, Michael Y. Chen, Samuel W. Kim, Ina Chen, Jesse T Davidson 4th, Narendra V. Sankpal, Jasreet Hundal, Lijin Li, Stephanie Myles, Rama Suresh, Cynthia X. Ma, Ademuyiwa Foluso, Andrea Wang-Gillam, Sherri Davies, Ian Hagemann, Elaine R. Mardis, Malachi Griffith, Christopher A. Miller, Ted H. Hansen, Timothy P. Fleming, Robert D. Schreiber, William E. Gillanders
medRxiv 2021.11.19.21266466; doi: https://doi.org/10.1101/2021.11.19.21266466
Neoantigen DNA vaccines are safe, feasible, and capable of inducing neoantigen-specific immune responses in patients with triple negative breast cancer
Xiuli Zhang, S. Peter Goedegebuure, Nancy B. Myers, Tammi Vickery, Michael D. McLellan, Feng Gao, Mark A. Sturmoski, Michael Y. Chen, Samuel W. Kim, Ina Chen, Jesse T Davidson 4th, Narendra V. Sankpal, Jasreet Hundal, Lijin Li, Stephanie Myles, Rama Suresh, Cynthia X. Ma, Ademuyiwa Foluso, Andrea Wang-Gillam, Sherri Davies, Ian Hagemann, Elaine R. Mardis, Malachi Griffith, Christopher A. Miller, Ted H. Hansen, Timothy P. Fleming, Robert D. Schreiber, William E. Gillanders
medRxiv 2021.11.19.21266466; doi: https://doi.org/10.1101/2021.11.19.21266466
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)